Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."

OTCPK:EMMBF - Post Discussion

Emblem Corp > Shareholders still have to vote
View:
Post by Dcoyote on Dec 19, 2018 12:38pm

Shareholders still have to vote

Hopefully they will vote no cause they can get a way way better deal than this.
Comment by fringelife on Dec 19, 2018 1:47pm
Even if they do vote no, this is still going to hurt this company's reputation now that we know this CEO will sell for cheap. 
Comment by HighGuy420 on Dec 19, 2018 4:55pm
I don't understand the benefit of selling so cheap by the CEO. I think people were right, this company was 2-3 quarters away from moving the needle to between $1.50 and $2.50 a share.  Unless they didn't have the financial runway to last that long. This deal also made all of executive leadership team's options useless, unless they will pick up new ones at a lower price!  I& ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities